| Literature DB >> 35624828 |
Ivan Fan Xia1,2, Hang-Kin Kong1,3, Margaret M H Wu1,3, Yishan Lu4,5, Ka-Hing Wong1,3, Kevin W H Kwok1,3.
Abstract
Selenium nanoparticles (SeNPs) are a novel elemental form selenium and often reported to possess beneficial bioactivities such as anticancer, promoting bone growth and immunomodulation. Our previous study demonstrated that chitosan-stabilized SeNPs have strong activity in immunomodulation. However, the mechanism underlying the immunomodulation of SeNPs is still unknown. The aim of this study is to identify the molecular mechanisms involved in SeNP-induced immunomodulation. Using zebrafish, as a common immunological animal model with a highly conserved molecular mechanism with other vertebrates, we conducted serum proteomic and tissue transcriptome analyses on individuals fed with SeNP in healthy or disease conditions. We also compared differences between SeNPs and an exogenous antioxidant Trolox in immune activity and redox regulation. Our results suggest that the immunomodulation activity was highly related to antioxidant activity and lipid metabolism. Interestingly, the biological functions enhanced by SeNP were almost identical in the healthy and disease conditions. However, while the SeNP was suppressing ROS in healthy individuals, it promoted ROS formation during disease condition. This might be related to the defense mechanism against pathogens. SOD and NFkβ appeared to be the key molecular switch changing effect of SeNPs when individuals undergo infection, indicating the close relationship between immune and redox regulation.Entities:
Keywords: Orbitrap tandem mass spectrometry; antioxidant; infection; lipid metabolism
Year: 2022 PMID: 35624828 PMCID: PMC9137598 DOI: 10.3390/antiox11050964
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Characterization of chitosan-stabilized SeNPs and the diet: (A) representative TEM image of SeNPs; (B) representative HR-TEM image of SeNPs (Inset: SAEN pattern of SeNPs); (C) size distribution of SeNPs by NanoSight (Mean: 129 nm, SD: 40 nm); (D) Elemental analysis by EDX spectrum; (E) representative image of SeNP diet; (F) representative TEM image of SeNP diet (black arrows indicated SeNPs attaching on fish diet particulates).
Figure 2Dietary SeNPs and Trolox-induced immune and antioxidant responses: (A) Bacterial challenge by Aeromonas hydrophila in the zebrafish fed with SeNP, Trolox or control diets; (B) Lysozyme activity; (C) Extracellular respiratory burst activity; (D) Intracellular respiratory burst activity; (E) Lymphocyte proliferation; (F) ROS concentration; (G) GSH concentration; (H) GPx activity; (I) CAT activity; (J) GR activity; (K) SOD activity. Different alphabets in the figure indicate statistically different groups where * p < 0.05.
Figure 3Serum proteomic analysis with/without dietary SeNPs in healthy and diseased conditions: (A) Experimental scheme of serum proteomic analysis; (B) Venn diagram depicting the total number of identified protein families in zebrafish serum from the control diet and SeNP diet in healthy conditions and control diet and SeNP diet in diseased condition. (C) Protein type category by IPA classification; (D) GO term biological processes analysis of serum proteins; (E) GO term molecular functions analysis of serum proteins.
Figure 4Top 15 enriched canonical pathways identified in IPA by DEPs in (A) healthy and (B) diseased conditions. The pathways are indicated on the y-axis. On the x-axis, the enrichment score (−log10(p-value)) for each pathway is indicated by the bars. (C) Healthy top molecular network involving free radical scavenging, small molecule biochemistry and drug metabolism. (D) Disease top molecular network in conditions involving carbohydrate metabolism, nucleic acid metabolism, small molecule biochemistry. Upregulated proteins are represented in red and downregulated proteins are represented in green. Orange represents predicted activation, while blue represents predicted inhibition.
The top three molecular networks based on differentially expressed proteins (DEPs) comparing the two diets under healthy and diseased conditions, respectively. DEPs are indicated in bold text.
| Analysis | ID | Molecules in Network | Score | Focus Molecules | Top Diseases and Functions |
|---|---|---|---|---|---|
| 1 | 45 | 22 | Free Radical Scavenging, Small Molecule Biochemistry, Drug Metabolism | ||
| 2 | 43 | 21 | Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism | ||
| 3 | Akt, C3, C5, C6, C7, C8, C1q, C3-Cfb, C5-C6-C7, C5-C6-C7-C8, C5-C6-C7-C8-C9, | 30 | 16 | Immunological Disease, Developmental Disorder, Hereditary Disorder | |
| 1 | 20s proteasome, | 44 | 22 | Carbohydrate Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry | |
| 2 | 41 | 21 | Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism | ||
| 3 | 38 | 20 | Immunological Disease, Developmental Disorder, Hereditary Disorder |
Figure 5Transcriptome analysis of Se-enriched tissues (liver and kidney): (A) Se concentration in seven tissues, including the brain, gill, gut, liver, kidney, gonad and muscle; (B) Venn diagram of DEGs in the liver and kidneys; (C) Volcano plots of kidney DEGs; (D) Volcano plots of liver DEGs; (E) Kidney DEG-enriched KEGG pathway; (F) Top 5 KEGG-enriched pathways in kidneys; (G) Liver DEG-enriched KEGG pathway; (H) Top 5 KEGG enriched pathway in the liver. * p < 0.05.